Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months

Article de revue

Avec comité de lecture

A. Sobrero, A. Grothey, S. Siena, A. Falcone, M. Ychou, Y. Humblet, O. Bouche, L. Mineur, C. Barone, A. Adenis, …

Annals of oncology, Vol.26, p.vi40

10/2015

Indicateurs

1 Consultations de la notice

Titre: Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months
Créateurs - sans rôle: A. Sobrero
A. Grothey
S. Siena
A. Falcone
M. Ychou
Y. Humblet
O. Bouche
L. Mineur
C. Barone
A. Adenis
J. Tabernero
T. Yoshino
H. Lenz
R.M. Goldberg
L. Xu
A. Wagner
E. Van Cutsem
Détails de publication: Annals of oncology, Vol.26, p.vi40
Identifiants: 99141165509311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article